Shares have been down in 2024, falling about 20% since the beginning of the year and closing on Tuesday at 34.33 Canadian dollars ($24.42). At that price, the value of the shares intended for buyback ...

Kronos Bio said it would cut about 83% of its workforce by the end of the year and named a new interim chief executive, as the company continues to explore strategic options. The San Mateo, Calif., ...

Symbotic reduced its quarterly guidance and said it will need more time to file its annual report after identifying an error in its system revenue recognition. The ...

Outlook Therapeutics will resubmit a biologics license application for its ophthalmic formulation of bevacizumab early next year after the second of two clinical trials missed a key target. The ...

Shares of GameStop Corp. continued their rise in premarket trades Wednesday, climbing 2% after ending Tuesday's session up 2.2%. The stock has risen on no apparent news recently, climbing for three ...

A flood of corporate bond issuance on Monday was followed Tuesday by the 22nd, no-print, non-Friday session of the year, ...

MEXICO CITY--Mexico posted a $371 million trade surplus in October, compared with a $369 million deficit in the year-ago month, with growth in exports outpacing imports. Exports rose 11.2% from the ...

Denison Mines has formed three joint ventures with Cosa Resources for three uranium properties in Saskatchewan. The Canadian uranium producer said Wednesday that Cosa will acquire 70% interest in ...

SolarEdge Technologies is cutting about 500 jobs as it shutters its energy storage business. The Israeli solar-power firm said Wednesday that the job cuts will reduce its total workforce by about 12% ...

Quarterhill has landed a pair of contracts in Idaho valued at $3.4 million for system upgrades and maintenance at commercial vehicle enforcement stations operated by the state police. The Canadian ...

The European Commission approved Tevimbra, the commercial name for Tislelizumab, in combination with chemotherapy for the first-line treatment of esophageal squamous cell carcinoma and gastric or ...

The 2025 forecasts continue to come thick and fast, and a notable projection is a fresh one from JPMorgan. For some time the ...